Universal Ibogaine Inc. (TSXV:IBO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0050
-0.0050 (-50.00%)
Feb 2, 2026, 9:30 AM EST
-75.00%
Market Cap 1.56M
Revenue (ttm) 2.06M
Net Income (ttm) -1.48M
Shares Out 312.86M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,660,150
Average Volume 241,304
Open 0.0050
Previous Close 0.0050
Day's Range 0.0050 - 0.0050
52-Week Range 0.0050 - 0.0450
Beta 4.61
RSI 42.68
Earnings Date Nov 28, 2025

About Universal Ibogaine

Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine Inc. is headquartered in Calgary, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Nicholas Karos
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol IBO
Full Company Profile

Financial Performance

In fiscal year 2024, Universal Ibogaine's revenue was 2.33 million, an increase of 126.32% compared to the previous year's 1.03 million. Losses were -2.05 million, -14.17% less than in 2023.

Financial Statements

News

There is no news available yet.